Roivant Sciences Ltd
Research Roivant Sciences Ltd (ROIV) on Bullrun: market cap USD 24.98B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerROIV
- ExchangeNASDAQ
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 24.98B
- Financial periodFY2026
- RevenueUSD 8.26M
- Revenue growth-71.6%
- Net income-USD 299.77M
- Free cash flow-USD 758.56M
Valuation Snapshot
latest market cap is USD 24.98B.
About Roivant Sciences Ltd
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease;
Frequently asked questions
What is Roivant Sciences Ltd's market cap?
Roivant Sciences Ltd's market capitalization is USD 24.98B.
What does Roivant Sciences Ltd do?
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.